Traumatic Intracranial Hemorrhage Clinical Trial
Official title:
Detecting Traumatic Intracranial Hemorrhage With Microwave Technology - An Open Study Evaluating the Diagnostic Accuracy of a Microwave-based Device to Detect Traumatic Intracranial Hemorrhage (TICH), by Comparing Measurements on Trauma Patients With Confirmed vs Excluded TICH
NCT number | NCT02728908 |
Other study ID # | TICH 01 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2016 |
Est. completion date | November 1, 2019 |
Verified date | January 2020 |
Source | Sahlgrenska University Hospital, Sweden |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
An open study evaluating the diagnostic accuracy of a microwave-based device to detect traumatic intracranial hemorrhage (TICH), by comparing measurements on trauma patients with confirmed vs excluded TICH
Status | Completed |
Enrollment | 250 |
Est. completion date | November 1, 2019 |
Est. primary completion date | November 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient admitted to Sahlgrenska University Hospital for trauma care. - Patient deemed clinically stable. - Patient should have a Glasgow Coma Scale rating of > 14 - TICH confirmed (group A) or ruled out (group B) by CT, performed within the latest 12 hours. - Patient = 18 years of age. - Patient has signed the Informed Consent Form. Exclusion Criteria: - Patient has confirmed or suspected skull fracture. - Patient has confirmed or suspected cervical spine fracture. - The diagnostic procedure is deemed to interfere with the standard of care. - Patient has a shunt or other foreign object implanted intracranially. - Patient has agraffes/other metal parts, thick (> 1 cm) bandage, or other foreign materials attached to the head that are deemed to interfere with the diagnostic procedure. - Any other condition or symptoms preventing the patient from entering the study, according to the Investigator's judgment. - Females who are pregnant. |
Country | Name | City | State |
---|---|---|---|
Sweden | Sahlgrenska University Hospital, Department of Surgery, Trauma Unit | Gothenburg | Västra Götaland |
Lead Sponsor | Collaborator |
---|---|
Hans Granhed | Chalmers University of Technology, Medfield Diagnostics |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The diagnostic ability as measured by the area under receiver operating characteristic curve (AUC) of the device for detecting TICH | The diagnostic ability of the device is calculated using a leave-one-out/n-fold cross-validation method | The diagnostic procedure has an estimated duration of 15 minutes | |
Secondary | The accuracy for estimating the position of the intracranial hemorrhage through a mathematical analysis of the microwave data | The diagnostic procedure has an estimated duration of 15 minutes | ||
Secondary | The accuracy for estimating the volume of the intracranial hemorrhage through a mathematical analysis of the microwave data | The diagnostic procedure has an estimated duration of 15 minutes | ||
Secondary | Mean time (± standard deviation) needed to complete the measurement procedure | The diagnostic procedure has an estimated duration of 15 minutes | ||
Secondary | Any adverse events occurring within 12 hours from the measurement procedure(s) | The diagnostic procedure has an estimated duration of 15 minutes, a safety follow-up will be performed 12 hours after the diagnostic procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05000060 -
Restart TICrH AP Pilot Trial
|
Phase 3 | |
Completed |
NCT05609721 -
Mild Traumatic Brain Injury and the Risk for Traumatic Intracranial Hemorrhage
|
||
Completed |
NCT05609734 -
No Cases of Delayed Intracranial Hemorrhage (d-ICH) Among Patients With Mild Traumatic Brain Injury (mTBI) on Oral Anticoagulation Therapy
|
||
Enrolling by invitation |
NCT06433622 -
Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy (Repeat TEG-PM)
|